1 |
Wang X, Men K, Liu DH, et al. Analysis on situation of antibiotic use of operation inpatients[J]. Chin J Public Health, 2007, 23(6): 710-711.
|
2 |
Zhai X, Wang YM, Gong P. Research progress of new type of ephedroxane[J]. J Shenyang Pharmaceutical Univ, 2006, 23(11): 739-744.
|
3 |
Lu YL, Sun LH. Cost-effectiveness analysis of 3 kinds of antimicrobial drugs for acute lithiasic cholecystitis[J]. Chin Pham, 2010, 21(24): 2271-2273.
|
4 |
Zhu SP, Gong J, Chang AH, et al. Clinical analysis of patients with preoperative gynecological and obstetrical surgery from a third-grade class-A hospital[J]. Chin J Public Health, 2012, 28(3): 412.
|
5 |
Zhu SP, Gong J, Hou HY, et al. A cross-section study on application time of antibactericals for gynecologic and obstetrics patients with surgical operation in a third grade hospital[J]. Chin J Public Health, 2012, 28(4): 427-428.
|
6 |
Zhu SP, Gong J, Hu CX, et al. Investigation of the application status of antibacterial drugs in patients with preoperative gynecological and obstetrical surgery from a third-grade class-A hospital[J/CD]. Chin J Obstet Gynecol Pedicatr: Electron Ed, 2012, 8(3): 388-390.
|
7 |
Zhu SP, Gong J, Liu YX, et al. Preoperative utilization of antibacterials for gynecologic and obstetric patients in a grade-three and class-A hospital[J]. Eval Anal Drug-use Hosp Chin, 2012, 12(7): 621-623.
|
8 |
Gong J, Pan W, Ni JH,et al. Pharmacoeconomic evaluation of antibacterials for gynecologic and obstetric patients undergoing surgical operation in a three-a hospital[J]. Eval Anal Drug-use Hosp Chin, 2012, 12(8): 788-591.
|
9 |
Zheng YR, Gong J, Lu SX, et al. Analysis of clinical features and antibacterical drugs usage in patients with peroprative gynecological and obstetrical surgery from a second-grade class-A hospital[J/CD]. Chin J Obstet Gynecol Pedicatr: Electron Ed, 2012, 8(5): 617-619.
|
10 |
Li D, Gong J, Wang YH, et al. A cross-section study on application time of antibactericals for gynecologic and obstetrics patients with surgical operation in a second grade hospital[J]. Pract Pharm Clin Remed, 2012, 15(8): 506-508.
|
11 |
Liu XY, Chen YW. Current status and countermeasures of irrational antibacterical drugs use in one hospital[J]. Chin Med Herald, 2012, 9(9): 118-121.
|
12 |
Wang YH, Yang Y. Analysis of antimicrobial usage of our hospital[J]. Chin Mod Doctor, 2010, 48(19): 43-44.
|
13 |
Gong J. Nonresponse in the pharmacoepidemilogy and its solution approaches[J]. Chin J Pharmacoepidemiol, 2012, 21(3): 142-145.
|
14 |
Yang CJ, Gong J, Zhou XM, et al. Clinical features of hospitalized patiens with thyroid disease from a third-class grade A hospital[J]. Pract Pharm Clin Remed, 2012, 15(4): 193-195.
|
15 |
Liang X, Ji LW. Investigation on the dermal test of cephalosporins[J]. Chin J Clin, 2009, 37(7): 60-61.
|
16 |
Hirsch BR, Lyman GH. Pharmacoeconomics of the myeloid growth factors: A critical and systematic review[J]. Pharmacoeconomics, 2012, 30(6): 497-511.
|